Drugs / Basal Insulin and Bolus Insulin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03051243 Comparator | Oct 2017 → Nov 2018 | type 2 diabetes mellitus | Rabin Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Basal Insulin and Bolus Insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03051243 ↗ |
| Known as | Apidra | “glulisine (Apidra; sanofi)” NCT03051243 ↗ |